Diyalo Technologies Pvt. Ltd. is thrilled to announce that it has successfully raised $24 million in its latest funding round, marking a significant milestone in the company’s journey towards innovation and community upliftment. Founded with a commitment to enhancing technological efficiency, Diyalo Technologies is dedicated to providing cutting-edge software solutions that are not only innovative but also accessible and affordable. With a diverse portfolio that includes Utility Billing Software, Travel Operator Management Systems, and a range of other bespoke solutions, the company has established itself as a leader in technology for various sectors. The newly acquired funding will be instrumental in accelerating Diyalo Technologies' mission to improve data accessibility and streamline operations across its product range. This financial boost will primarily be utilized for the expansion of existing software offerings, the development of new integrated web portals, and the enhancement of customer support services, ensuring that all clients receive top-notch assistance. Furthermore, the funding will allow Diyalo Technologies to invest in research and development, ultimately paving the way for even more innovative solutions that can adapt to the evolving needs of industries such as utilities, travel, and political management. This significant investment not only reinforces the confidence investors have in Diyalo Technologies' vision but also underscores the importance of technology in uplifting communities through accessible solutions. We are immensely excited about the future and look forward to continuing our journey in empowering businesses with state-of-the-art technology.
Diyalo Technologies Pvt. Ltd. Secures $24 Million in Series A Funding for Revolutionary Technology Solutions
Get the full Diyalo Technologies Pvt. Ltd company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Beeline Medicines
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients. Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.
$126.3M Series a
today
Revoraai
Most real estate businesses don’t have a lead problem. They have a conversion problem. Leads come in… But slow replies, missed follow-ups, and unqualified inquiries kill deals. That’s where I help. I build AI-powered systems that: • Instantly respond to new leads • Filter serious buyers • Follow up automatically • Turn conversations into site visits No manual chasing. No missed opportunities. Just a smarter way to convert leads into revenue. If you're in real estate and want to automate your lead flow, let’s connect.
$2.0M Seed
today
LEKO
LEKO Labs is accelerating the global transition to carbon negative construction with building materials powered by AI optimization and robotic manufacturing.
$9.0M Seed
today
Wolf-e Robotics
EU Manufacturer of Smart #UVC Disinfection Devices. Air Purifiers, Applied UV Robotics, Research & Development Platform. Gausium cleaning robots distributor. Democratizing clean air and surfaces in any indoor space. For collabs & enquiries, check our website: www.wolfe.ro.
$54.0K Unknown
today
OxidOS Automotive
OxidOS Automotive is building the next generation of software development tools and Operating Systems for Automotive ECUs, fully written in Rust. The OxidOS platform and Operating System allow automotive manufacturers and integrators to deploy safe and secure software faster, through development, debugging, and certification time reduction.
$54.0K Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Beeline Medicines United States | Series a | $126.3M | today |
| 2 |  Tomato Jos Nigeria | Series a | $4.0M | today |
| 3 |  Sycamore.NG Nigeria | Series a | $6.0M | today |
| 4 |  BFREE United States | Series a | $5.0M | today |
| 5 |  Ognomy Sleep United States | Series a | $20.0M | today |